The core difference between intravenous and oral NAD+ is delivery, not the molecule. Oral precursors must survive digestion and the liver before reaching the bloodstream, so only a fraction arrives intact; an infusion places the compound directly into circulation. Both can raise NAD+, but they differ in absorption, dose control and cost over time.
If you already take an oral NAD+ precursor and wonder whether an infusion is worth the step up — or you are new to the topic and comparing options from scratch, perhaps on behalf of a parent or partner exploring longevity protocols — this article is written for you. It is deliberately narrow. We are not re-explaining what NAD+ is or everything an infusion may do; we cover that in our full guide, NAD+ IV Infusion: What It Does and Why It Matters. Read that first if you want the foundations. Here, we focus on one decision only: oral supplementation versus intravenous delivery, and how to think about it honestly.
IV versus oral NAD+: what actually differs?
The difference is the route into the body, and everything that follows from it. Oral supplements are convenient, self-administered and inexpensive per dose; intravenous delivery is clinical, supervised and designed to bypass the absorption losses that oral forms face.
It is worth being precise about what is being taken. Most oral products are not NAD+ itself but precursors — commonly nicotinamide riboside (NR) or nicotinamide mononucleotide (NMN) — which the body converts into NAD+. Intravenous protocols typically deliver NAD+ (or a precursor) into a vein over a slow infusion. So the comparison is rarely “the same thing, two ways.” It is usually a precursor taken daily by mouth versus a compound delivered directly into the blood on a scheduled basis. That distinction shapes both the pharmacology and the cost.
Why does the route of delivery change how much NAD+ reaches your cells?
Because anything swallowed must pass through the gut and the liver before it reaches general circulation — a process known as first-pass metabolism. An infusion skips that journey and enters the bloodstream directly.
When you swallow a capsule, the contents are absorbed across the intestinal wall and travel first to the liver, where a significant proportion is metabolised before it ever reaches the rest of the body. Oral NAD+ precursors are specifically subject to this. A 2026 real-world pilot in Frontiers in Aging notes that oral NAD+ supplementation involves substantial first-pass metabolism resulting in variable conversion before the compound reaches the systemic pool. The foundational human work on nicotinamide riboside by Trammell and colleagues, published in Nature Communications in 2016, likewise established that NR is uniquely orally bioavailable precisely because bioavailability differs so much between the various precursor forms — in other words, the route and the molecule together determine how much survives.
Intravenous delivery is designed to sidestep that bottleneck. By entering the vein directly, the compound avoids gut degradation and hepatic first-pass loss, which is the pharmacological rationale clinicians give for the route. It is not that oral forms “do not work” — it is that a known fraction is lost before absorption, and infusion is intended to avoid that specific loss.
Does oral NAD+ supplementation actually raise NAD+ levels?
Yes — this is well established in humans, and it matters that we say so plainly. Oral precursors reliably increase blood NAD+ in a dose-dependent way.
In a controlled trial published in Scientific Reports in 2019, daily oral nicotinamide riboside raised whole blood NAD+ by 22%, 51% and 142% at doses of 100, 300 and 1000 mg respectively by day 14, with the higher doses reaching significance within the first week. So the honest position is not “oral does nothing.” Oral supplementation demonstrably moves the needle on circulating NAD+. The open question is how directly that translates into the outcomes people actually care about, and how it compares to an infusion — which is a separate matter from whether blood levels rise at all.
When is oral supplementation a reasonable starting point?
For many people, it is. If your goal is a steady, low-effort way to support NAD+ levels and you have no urgent clinical driver, a quality oral precursor is a sensible, evidence-backed place to begin.
Oral supplementation is inexpensive per dose, requires no appointment, and — as the trial data show — genuinely raises blood NAD+ over weeks of consistent use. For someone healthy who is simply curious about longevity protocols, starting oral is entirely reasonable, and it avoids committing to a clinical service before you know whether you value the effect. If you are researching for a relative, this is often the least disruptive first step: it fits into a daily routine without travel or supervision. The trade-off is that you accept the absorption losses described above, and that consistency over months is what produces the measurable change.
When do people consider intravenous delivery instead?
People typically consider an infusion when they want to bypass oral absorption limits, achieve higher circulating levels than daily capsules provide, or receive treatment under clinical supervision with individualised dosing.
Common reasons include finding oral supplementation underwhelming despite consistent use, wanting a supervised protocol as part of a broader wellness or recovery plan, or preferring dosing that a clinician controls and adjusts rather than a fixed capsule. It is important to be candid here: while the pharmacological logic for bypassing first-pass metabolism is sound, direct head-to-head human evidence remains thin. The same 2026 pilot notes there are no trials to date comparing clinical outcomes directly between routes, and that human data on intravenous efficacy are still limited. So the case for IV rests on mechanism and clinical experience more than on definitive comparative trials — and anyone claiming otherwise is overstating what is known.
How do the costs compare over time?
Oral supplements cost little per dose but are taken indefinitely; infusions cost more per session but are episodic. Neither is simply “cheaper” — they have different cost structures.
A daily oral precursor is modest month to month, yet the commitment is open-ended: the levels return towards baseline if you stop, so the expense recurs for as long as you continue, quietly compounding over years. An infusion carries a higher cost per visit but is delivered on a schedule rather than daily. When comparing, look past the sticker price of a single unit and consider the total over the horizon you actually plan to maintain the protocol, alongside the practical value you place on supervision and dose control. This is general market context rather than a recommendation of one route; the right answer depends on your goals, not on cost alone.
How Holina Clinic Approaches NAD+ Delivery
Holina Clinic offers intravenous NAD+ infusion service as an established part of our regenerative and longevity offering, delivered on-site across our Koh Phangan and Khao Yai campuses in Thailand. We treat delivery as a clinical decision, not a default.
Every patient begins with an individualised assessment. We take a full history, discuss your goals, and — where appropriate — use advanced diagnostics to understand your baseline before anything is recommended. That assessment is where the oral-versus-intravenous question is answered honestly for your situation: for some people, continuing or starting an oral precursor is the pragmatic choice, and we will say so; for others, a supervised infusion protocol suits their goals better. We do not present the infusion as universally superior, and we are candid that the comparative human evidence is still maturing.
What we can offer is a clinical setting, transparent explanation of what the science does and does not support, and dosing overseen by a clinician rather than a fixed template. Whether you are already taking oral NAD+ and weighing the next step, new to the topic, or researching for a family member, the sensible starting point is a conversation. You are welcome to contact our clinical team to ask questions and understand whether an assessment makes sense for you.
“The route matters, but it is not a competition with a single winner. Oral precursors genuinely raise NAD+ and suit many people; intravenous delivery is designed to bypass the absorption losses that oral forms face, which is why some patients choose it. What I resist is overselling either one — the direct comparative evidence in humans is still limited, so we make the decision case by case, honestly,” says Dr. Natalie Lindemann, Clinical Director (Global) at Holina Global.
Frequently asked questions
Is IV NAD+ better than oral supplements?
Not automatically. Intravenous delivery bypasses the digestion and liver metabolism that reduce oral absorption, but direct head-to-head human outcome data are limited. The better route depends on your goals, not a blanket ranking.
Do oral NAD+ supplements actually work?
Yes. Controlled trials show oral nicotinamide riboside raises whole blood NAD+ in a dose-dependent way, by as much as 142% at 1000 mg per day in one study. They demonstrably increase circulating NAD+.
Why does an infusion get more into my system than a capsule?
Anything swallowed passes through the gut and liver first, where much of it is metabolised before reaching general circulation. An infusion enters the bloodstream directly and avoids that first-pass loss.
What is the difference between NAD+, NR and NMN?
NAD+ is the coenzyme itself. NR (nicotinamide riboside) and NMN (nicotinamide mononucleotide) are precursors the body converts into NAD+. Most oral supplements are precursors; infusions often deliver NAD+ or a precursor directly.
I already take oral NAD+ — is switching to IV worth it?
It can be, if oral supplementation feels underwhelming or you want supervised, adjustable dosing. It is best decided in an individual assessment rather than assumed, since both routes have a role.
Is intravenous NAD+ safe?
It should only be given under clinical supervision after an individual assessment. Reported effects during infusion are usually related to the rate of delivery, which is why it is administered slowly by trained staff.
How often would I need an infusion compared with taking capsules?
Oral precursors are taken daily and indefinitely. Infusions are delivered on a schedule set by your clinician rather than every day. Frequency should be individualised, not copied from a generic package.
Is IV NAD+ more cost-effective than oral over time?
They have different cost structures rather than a clear winner. Oral is low-cost per dose but open-ended; infusions cost more per session but are episodic. Compare the total over the period you plan to continue.
Can I just take a higher oral dose instead of an infusion?
Higher oral doses do raise NAD+ further, but absorption losses still apply, and dosing should be discussed with a clinician. A higher capsule dose and an infusion are not directly equivalent.
Is there proof IV NAD+ works better than oral?
Not definitively. A 2026 review notes no trials have yet compared clinical outcomes directly between routes, and human IV efficacy data remain limited. The case rests on mechanism and clinical experience.
I’m researching this for a family member — where should we start?
Start with the fundamentals, then an individual assessment. Read our full guide to what NAD+ infusion does, then discuss suitability with a clinician who can weigh oral versus intravenous for their specific situation.
Does Holina Clinic offer NAD+ infusions?
Yes, on-site across our Koh Phangan and Khao Yai campuses, following an individualised clinical assessment. You are welcome to contact our team to discuss whether it is appropriate for you.
Clinically reviewed by Dr. Natalie Lindemann — Clinical Director, Holina Global · Last reviewed 20 July 2026.
